Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YJG0 | ISIN: TH1027010012 | Ticker-Symbol: I93
Frankfurt
24.01.25
08:18 Uhr
0,645 Euro
+0,025
+4,03 %
Branche
Chemie
Aktienmarkt
ASIEN
1-Jahres-Chart
INDORAMA VENTURES PCL Chart 1 Jahr
5-Tage-Chart
INDORAMA VENTURES PCL 5-Tage-Chart
RealtimeGeldBriefZeit
0,6300,72524.01.
PR Newswire
283 Leser
Artikel bewerten:
(1)

INDORAMA VENTURES, ONE OF WORLD'S TOP 30 GLOBAL CHEMICALS COMPANIES, GOES LIVE ON GEP'S AI-DRIVEN SOFTWARE, TRANSFORMING ITS PROCUREMENT OPERATIONS AND DRIVING NEW VALUE

Finanznachrichten News
  • Indorama Ventures goes live with GEP SOFTWARE's source-to-contract (S2C) and eAuctions solutions in North Americas, with APAC and EMEA to follow
  • GEP's Intelligent Category Management (ICM) provides real-time intelligence into all direct and indirect spend

CLARK, N.J., Nov. 5, 2024 /PRNewswire/ -- GEP®, a leading provider of AI-driven procurement and supply chain software and services to Fortune 500 and Global 2000 enterprises worldwide, announced today that Indorama Ventures Public Company Limited, a global sustainable chemicals company, went liveon GEP SOFTWARE, the industry's leading procurement and supply chain platform.

GEP Logo

Headquartered in Bangkok, Indorama Ventures is one of the world's leading producers of PET, polyester yarns and fibers, and specialty chemicals, generating revenue of $15.6 billion in 2023. The company's 26,000 employees produce "indispensable chemistry" in more than 30 countries. Indorama Ventures is using GEP SOFTWARE to help transform its global procurement process, aligning with its IVL 2.0 transformation and Procurement 4.0 journey, through encompassing eAuctions, sourcing and contract management, spend analytics, and supplier management. GEP's Intelligent Category Management (ICM) is enabling Indorama Ventures' category managers to apply should-cost modeling, cost breakdowns and "what if" scenario modeling to identify cost savings in both indirect and direct purchases.

Sanjay Ahuja, Indorama Ventures' chief strategy and transformation officer, said, "Leveraging GEP's software aligns with our digital transformation and IVL 2.0 strategy, enabling us to more effectively manage our supply chain and procurement processes. This helps us to streamline our production and consequently enhances our reliability and value delivery to our customers. It also strengthens our ability to manage growth and mitigate risks in an increasingly complex market environment." GEP's AI-driven software platform provides a full range of low-code solutions to realize Indorama Ventures' vision by:

  • Increasing visibility into the entire S2C procurement process, providing better insights to uncover and drive new value
  • Leveraging strategic sourcing tools to identify cost-saving opportunities, negotiate effectively, and build strong supplier relationships
  • Mitigating risk by enabling comprehensive supplier performance evaluation
  • Strengthening its procurement operation by automating routine tasks and improving overall efficiency across global operations

GEP SOFTWARE encompasses GEP SMART, named the world's best procurement software for the second year in a row, GEP NEXXE, the next-generation cloud-native supply chain unified platform, and GEP GREEN to measure and advance sustainability. GEP SOFTWARE is powered by GEP QUANTUM, the industry's leading AI-first, low-code platform.

About GEP SOFTWARE

GEP SOFTWARE provides AI-powered digital procurement and supply chain platforms that help global enterprises become more agile, resilient, competitive and profitable. With beautifully rendered interfaces and flexible workflows, GEP provides users fresh, intuitive digital workspaces that yield extraordinary levels of user adoption and meaningful gains in team and personal productivity.

GEP products capitalize on machine learning and cognitive computing, advanced data and semantic technologies, IoT, mobile and cloud technologies, and are designed to incorporate continual innovations in technology. GEP's software integrates quickly and easily with third-party and legacy systems, such as SAP, Oracle and all other major ERP and F&A software. And with superb support and service, GEP is an industry leader in customer satisfaction and loyalty.

A leader in multiple Gartner Magic Quadrants, GEP's cloud-native software and digital business platforms consistently win awards and recognition from industry analysts, research firms and media outlets, including Gartner, Forrester, IDC, Procurement Leaders and Spend Matters.

GEP SOFTWARE is part of Clark, NJ-based GEP - the world's leading provider of AI-powered procurement and supply chain software, strategy and managed services. To learn more, visit www.gepsoftware.com.

Media Contact

Derek Creevey
GEP
Phone: +1 732-382-6565
Email: derek.creevey@gep.com

Logo - https://mma.prnewswire.com/media/518346/GEP_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/indorama-ventures-one-of-worlds-top-30-global-chemicals-companies-goes-live-on-geps-ai-driven-software-transforming-its-procurement-operations-and-driving-new-value-302295971.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.